FIELD: chemistry.
SUBSTANCE: invention relates to a novel platinum (IV) complex with a "cis-trans-cis" configuration of ligands of formula (III): 
(III). Method for preparing a platinum complex and a pharmaceutical composition for treating a neoplastic disease comprising said complex are also provided.
EFFECT: platinum (IV) complex of formula (III) has excellent antitumor properties and low toxicity as compared to the prior art platinum complexes used or investigated.
8 cl, 3 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PLATINUM IV COMPLEXES WITH ESSENTIALLY INCREASED ANTITUMOR EFFICIENCY | 2019 |
|
RU2802514C1 |
| TRIPLATINUM (II) COMPLEXES, AND METHOD OF PREPARING THEREOF | 1994 |
|
RU2140422C1 |
| TRINUCLEAR CATIONIC PLATINUM COMPLEXES HAVING ANTITUMOR ACTIVITY, METHOD OF PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPLEXES | 1995 |
|
RU2130941C1 |
| PLATINUM COMPLEX COMPOUNDS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203901C2 |
| PLATINUM COMPLEX COMPOUNDS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2200164C2 |
| COMBINED CHEMOTHERAPY | 2001 |
|
RU2284818C2 |
| PHARMACEUTICAL COMPOSITION FOR INJECTION PARTICULARLY TARGETED LOCAL ADMINISTRATION | 2007 |
|
RU2440113C2 |
| COMBINED CHEMOTHERAPY | 2010 |
|
RU2587013C2 |
| COMBINED CHEMOTHERAPY | 2006 |
|
RU2429838C2 |
| ORAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2430718C2 |
